Occurrence of antibodies against herpes simplex virus thymidine kinase in human sera
- 1 January 1981
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 8 (3) , 177-186
- https://doi.org/10.1002/jmv.1890080304
Abstract
The 17D vaccine strain of yellow fever virus (17D‐YF) produces a safe human arboviral infection that can provide antisera of well‐defined specificity under chronologically defined conditions. We studied 17D‐YF growth in human peripheral blood macrophages and in two continuous Fc receptor‐bearing, macrophage‐like cell lines, P388D of mouse origin and U937 of human origin. Cells were infected with virus in the presence or absence of antibody to 17D‐YF and to two related flaviviruses, St. Louis encephalitis (SLE) and dengue 2 (D2V). The virus 17D‐YF grew in the three cell types when infection was established without antibody; viral yields were increased by addition of antibody to 17D‐YF, SLE, and D2V. Increased titers of virus were accompanied by an increased number of infected cells by immunofluorescent assay. Enhancing activity was present in the IgG but not the IgM fractions of immune sera. Infection without cytopathic effect was observed in U937.Keywords
This publication has 15 references indexed in Scilit:
- Viral-associated and induced enzymesPharmacology & Therapeutics, 1979
- Detection of Herpesvirus Type-Specific Antibody by a Micro Solid Phase Radioimmunometric AssayIntervirology, 1979
- DNA Polymerase in Pseudorabies Virus Infected CellsJournal of General Virology, 1976
- Serological Properties of Thymidine Kinase Produced in Cells Infected with Type 1 or Type 2 Herpes VirusJournal of General Virology, 1972
- A virus-specific thymidine kinase in BHK21 cells infected with herpes simplex virusVirology, 1967
- Immunological evidence for a specific DNA polymerase produced after infection by herpes simplex virusVirology, 1966